context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
The following unaudited supplemental pro forma financial information presents the financial results from continuing operations for the year ended December 31, 2022 as if the Elkay Merger had occurred on January 1, 2022. The pro forma financial information includes, where applicable, adjustments for: (i) additional amortization expense that would have been recognized related to the acquired intangible assets, (ii) additional depreciation expense that would have been recognized related to the acquired property, plant, and equipment, and (iii) the estimated income tax effect on the pro forma adjustments. Expenses in the year ended December 31, 2022 include $ 33.7 million of transaction costs and other one-time non-recurring costs and $ 18.3 million of cost of sales related to the inventory valuation adjustment. The pro forma financial information excludes adjustments for estimated cost synergies or other effects of the integration of the Elkay Merger. | text | 18.3 | monetaryItemType | text: <entity> 18.3 </entity> <entity type> monetaryItemType </entity type> <context> The following unaudited supplemental pro forma financial information presents the financial results from continuing operations for the year ended December 31, 2022 as if the Elkay Merger had occurred on January 1, 2022. The pro forma financial information includes, where applicable, adjustments for: (i) additional amortization expense that would have been recognized related to the acquired intangible assets, (ii) additional depreciation expense that would have been recognized related to the acquired property, plant, and equipment, and (iii) the estimated income tax effect on the pro forma adjustments. Expenses in the year ended December 31, 2022 include $ 33.7 million of transaction costs and other one-time non-recurring costs and $ 18.3 million of cost of sales related to the inventory valuation adjustment. The pro forma financial information excludes adjustments for estimated cost synergies or other effects of the integration of the Elkay Merger. </context> | us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss |
For the period from July 1, 2022 through December 31, 2022, Elkay had net sales and a net loss of $ 264.4 million and $ 11.5 million, respectively, which include the impact of purchase accounting adjustments, and are included in the consolidated statements of operations for the period from July 1, 2022 through December 31, 2022. | text | 264.4 | monetaryItemType | text: <entity> 264.4 </entity> <entity type> monetaryItemType </entity type> <context> For the period from July 1, 2022 through December 31, 2022, Elkay had net sales and a net loss of $ 264.4 million and $ 11.5 million, respectively, which include the impact of purchase accounting adjustments, and are included in the consolidated statements of operations for the period from July 1, 2022 through December 31, 2022. </context> | us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual |
For the period from July 1, 2022 through December 31, 2022, Elkay had net sales and a net loss of $ 264.4 million and $ 11.5 million, respectively, which include the impact of purchase accounting adjustments, and are included in the consolidated statements of operations for the period from July 1, 2022 through December 31, 2022. | text | 11.5 | monetaryItemType | text: <entity> 11.5 </entity> <entity type> monetaryItemType </entity type> <context> For the period from July 1, 2022 through December 31, 2022, Elkay had net sales and a net loss of $ 264.4 million and $ 11.5 million, respectively, which include the impact of purchase accounting adjustments, and are included in the consolidated statements of operations for the period from July 1, 2022 through December 31, 2022. </context> | us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual |
The Company had backlog of $ 48.8 million and $ 50.8 million as of December 31, 2024, and December 31, 2023, respectively, which represents the most likely amount of consideration expected to be received in satisfying the remaining backlog under open contracts. The Company utilizes the optional exemption provided by ASC 606-10-50-14A for variable consideration, and has not included estimated rebates in the amount of unsatisfied performance obligations. The Company expects to recognize approximately 100 % of the backlog as revenue in the year ending December 31, 2025. | text | 48.8 | monetaryItemType | text: <entity> 48.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company had backlog of $ 48.8 million and $ 50.8 million as of December 31, 2024, and December 31, 2023, respectively, which represents the most likely amount of consideration expected to be received in satisfying the remaining backlog under open contracts. The Company utilizes the optional exemption provided by ASC 606-10-50-14A for variable consideration, and has not included estimated rebates in the amount of unsatisfied performance obligations. The Company expects to recognize approximately 100 % of the backlog as revenue in the year ending December 31, 2025. </context> | us-gaap:RevenueRemainingPerformanceObligation |
The Company had backlog of $ 48.8 million and $ 50.8 million as of December 31, 2024, and December 31, 2023, respectively, which represents the most likely amount of consideration expected to be received in satisfying the remaining backlog under open contracts. The Company utilizes the optional exemption provided by ASC 606-10-50-14A for variable consideration, and has not included estimated rebates in the amount of unsatisfied performance obligations. The Company expects to recognize approximately 100 % of the backlog as revenue in the year ending December 31, 2025. | text | 50.8 | monetaryItemType | text: <entity> 50.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company had backlog of $ 48.8 million and $ 50.8 million as of December 31, 2024, and December 31, 2023, respectively, which represents the most likely amount of consideration expected to be received in satisfying the remaining backlog under open contracts. The Company utilizes the optional exemption provided by ASC 606-10-50-14A for variable consideration, and has not included estimated rebates in the amount of unsatisfied performance obligations. The Company expects to recognize approximately 100 % of the backlog as revenue in the year ending December 31, 2025. </context> | us-gaap:RevenueRemainingPerformanceObligation |
The Company had backlog of $ 48.8 million and $ 50.8 million as of December 31, 2024, and December 31, 2023, respectively, which represents the most likely amount of consideration expected to be received in satisfying the remaining backlog under open contracts. The Company utilizes the optional exemption provided by ASC 606-10-50-14A for variable consideration, and has not included estimated rebates in the amount of unsatisfied performance obligations. The Company expects to recognize approximately 100 % of the backlog as revenue in the year ending December 31, 2025. | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The Company had backlog of $ 48.8 million and $ 50.8 million as of December 31, 2024, and December 31, 2023, respectively, which represents the most likely amount of consideration expected to be received in satisfying the remaining backlog under open contracts. The Company utilizes the optional exemption provided by ASC 606-10-50-14A for variable consideration, and has not included estimated rebates in the amount of unsatisfied performance obligations. The Company expects to recognize approximately 100 % of the backlog as revenue in the year ending December 31, 2025. </context> | us-gaap:RevenueRemainingPerformanceObligationPercentage |
Intangible asset amortization expense totaled $ 59.1 million, $ 58.7 million and $ 34.0 million for the years ended December 31, 2024, 2023, and 2022, respectively. There were no acquired intangibles in 2024 or 2023. Customer relationships and tradenames acquired during the year ended December 31, 2022 were assigned a weighted-average useful life of 16 years and 20 years, respectively. | text | 59.1 | monetaryItemType | text: <entity> 59.1 </entity> <entity type> monetaryItemType </entity type> <context> Intangible asset amortization expense totaled $ 59.1 million, $ 58.7 million and $ 34.0 million for the years ended December 31, 2024, 2023, and 2022, respectively. There were no acquired intangibles in 2024 or 2023. Customer relationships and tradenames acquired during the year ended December 31, 2022 were assigned a weighted-average useful life of 16 years and 20 years, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
Intangible asset amortization expense totaled $ 59.1 million, $ 58.7 million and $ 34.0 million for the years ended December 31, 2024, 2023, and 2022, respectively. There were no acquired intangibles in 2024 or 2023. Customer relationships and tradenames acquired during the year ended December 31, 2022 were assigned a weighted-average useful life of 16 years and 20 years, respectively. | text | 58.7 | monetaryItemType | text: <entity> 58.7 </entity> <entity type> monetaryItemType </entity type> <context> Intangible asset amortization expense totaled $ 59.1 million, $ 58.7 million and $ 34.0 million for the years ended December 31, 2024, 2023, and 2022, respectively. There were no acquired intangibles in 2024 or 2023. Customer relationships and tradenames acquired during the year ended December 31, 2022 were assigned a weighted-average useful life of 16 years and 20 years, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
Intangible asset amortization expense totaled $ 59.1 million, $ 58.7 million and $ 34.0 million for the years ended December 31, 2024, 2023, and 2022, respectively. There were no acquired intangibles in 2024 or 2023. Customer relationships and tradenames acquired during the year ended December 31, 2022 were assigned a weighted-average useful life of 16 years and 20 years, respectively. | text | 34.0 | monetaryItemType | text: <entity> 34.0 </entity> <entity type> monetaryItemType </entity type> <context> Intangible asset amortization expense totaled $ 59.1 million, $ 58.7 million and $ 34.0 million for the years ended December 31, 2024, 2023, and 2022, respectively. There were no acquired intangibles in 2024 or 2023. Customer relationships and tradenames acquired during the year ended December 31, 2022 were assigned a weighted-average useful life of 16 years and 20 years, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
During the year ended December 31, 2024, the Company recorded a $ 0.6 million impairment charge related to an indefinite-lived tradename no longer used. | text | 0.6 | monetaryItemType | text: <entity> 0.6 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company recorded a $ 0.6 million impairment charge related to an indefinite-lived tradename no longer used. </context> | us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill |
The Company expects to recognize amortization expense on intangible assets subject to amortization of $ 58.6 million in 2025, $ 58.4 million in 2026, $ 58.4 million in 2027, $ 58.4 million in 2028, and $ 58.4 million in 2029. | text | 58.6 | monetaryItemType | text: <entity> 58.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects to recognize amortization expense on intangible assets subject to amortization of $ 58.6 million in 2025, $ 58.4 million in 2026, $ 58.4 million in 2027, $ 58.4 million in 2028, and $ 58.4 million in 2029. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths |
The Company expects to recognize amortization expense on intangible assets subject to amortization of $ 58.6 million in 2025, $ 58.4 million in 2026, $ 58.4 million in 2027, $ 58.4 million in 2028, and $ 58.4 million in 2029. | text | 58.4 | monetaryItemType | text: <entity> 58.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects to recognize amortization expense on intangible assets subject to amortization of $ 58.6 million in 2025, $ 58.4 million in 2026, $ 58.4 million in 2027, $ 58.4 million in 2028, and $ 58.4 million in 2029. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo |
The Company expects to recognize amortization expense on intangible assets subject to amortization of $ 58.6 million in 2025, $ 58.4 million in 2026, $ 58.4 million in 2027, $ 58.4 million in 2028, and $ 58.4 million in 2029. | text | 58.4 | monetaryItemType | text: <entity> 58.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects to recognize amortization expense on intangible assets subject to amortization of $ 58.6 million in 2025, $ 58.4 million in 2026, $ 58.4 million in 2027, $ 58.4 million in 2028, and $ 58.4 million in 2029. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree |
The Company expects to recognize amortization expense on intangible assets subject to amortization of $ 58.6 million in 2025, $ 58.4 million in 2026, $ 58.4 million in 2027, $ 58.4 million in 2028, and $ 58.4 million in 2029. | text | 58.4 | monetaryItemType | text: <entity> 58.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects to recognize amortization expense on intangible assets subject to amortization of $ 58.6 million in 2025, $ 58.4 million in 2026, $ 58.4 million in 2027, $ 58.4 million in 2028, and $ 58.4 million in 2029. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour |
The Company expects to recognize amortization expense on intangible assets subject to amortization of $ 58.6 million in 2025, $ 58.4 million in 2026, $ 58.4 million in 2027, $ 58.4 million in 2028, and $ 58.4 million in 2029. | text | 58.4 | monetaryItemType | text: <entity> 58.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects to recognize amortization expense on intangible assets subject to amortization of $ 58.6 million in 2025, $ 58.4 million in 2026, $ 58.4 million in 2027, $ 58.4 million in 2028, and $ 58.4 million in 2029. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive |
$ 5.4 million and $ 6.8 million | text | 5.4 | monetaryItemType | text: <entity> 5.4 </entity> <entity type> monetaryItemType </entity type> <context> $ 5.4 million and $ 6.8 million </context> | us-gaap:DebtInstrumentUnamortizedDiscount |
$ 5.4 million and $ 6.8 million | text | 6.8 | monetaryItemType | text: <entity> 6.8 </entity> <entity type> monetaryItemType </entity type> <context> $ 5.4 million and $ 6.8 million </context> | us-gaap:DebtInstrumentUnamortizedDiscount |
On October 4, 2021, ZBS Global, Inc. (“Holdings”), Zurn Holdings, Inc., Zurn LLC (together, the “Original Borrowers”), the lenders from time to time party thereto, and Credit Suisse AG, Cayman Islands Branch, as administrative agent for the lenders (in such capacity, the “Administrative Agent”) entered into a Fourth Amended and Restated First Lien Credit Agreement as amended by that certain Amendment No. 1 to Fourth Amended and Restated First Lien Credit Agreement dated as of July 1, 2022 (the "Amendment") (as so amended, the “Credit Agreement”). Pursuant to the Amendment, Elkay joined the Credit Agreement as a borrower (Elkay and the Original Borrowers, collectively, the "Borrowers"). The Credit Agreement is funded by a syndicate of banks and other financial institutions and provides for (i) a $ 550.0 million term loan facility (the “Term Loan”) and (ii) a $ 200.0 million revolving credit facility (the “Revolving Credit Facility”). | text | 550.0 | monetaryItemType | text: <entity> 550.0 </entity> <entity type> monetaryItemType </entity type> <context> On October 4, 2021, ZBS Global, Inc. (“Holdings”), Zurn Holdings, Inc., Zurn LLC (together, the “Original Borrowers”), the lenders from time to time party thereto, and Credit Suisse AG, Cayman Islands Branch, as administrative agent for the lenders (in such capacity, the “Administrative Agent”) entered into a Fourth Amended and Restated First Lien Credit Agreement as amended by that certain Amendment No. 1 to Fourth Amended and Restated First Lien Credit Agreement dated as of July 1, 2022 (the "Amendment") (as so amended, the “Credit Agreement”). Pursuant to the Amendment, Elkay joined the Credit Agreement as a borrower (Elkay and the Original Borrowers, collectively, the "Borrowers"). The Credit Agreement is funded by a syndicate of banks and other financial institutions and provides for (i) a $ 550.0 million term loan facility (the “Term Loan”) and (ii) a $ 200.0 million revolving credit facility (the “Revolving Credit Facility”). </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
On October 4, 2021, ZBS Global, Inc. (“Holdings”), Zurn Holdings, Inc., Zurn LLC (together, the “Original Borrowers”), the lenders from time to time party thereto, and Credit Suisse AG, Cayman Islands Branch, as administrative agent for the lenders (in such capacity, the “Administrative Agent”) entered into a Fourth Amended and Restated First Lien Credit Agreement as amended by that certain Amendment No. 1 to Fourth Amended and Restated First Lien Credit Agreement dated as of July 1, 2022 (the "Amendment") (as so amended, the “Credit Agreement”). Pursuant to the Amendment, Elkay joined the Credit Agreement as a borrower (Elkay and the Original Borrowers, collectively, the "Borrowers"). The Credit Agreement is funded by a syndicate of banks and other financial institutions and provides for (i) a $ 550.0 million term loan facility (the “Term Loan”) and (ii) a $ 200.0 million revolving credit facility (the “Revolving Credit Facility”). | text | 200.0 | monetaryItemType | text: <entity> 200.0 </entity> <entity type> monetaryItemType </entity type> <context> On October 4, 2021, ZBS Global, Inc. (“Holdings”), Zurn Holdings, Inc., Zurn LLC (together, the “Original Borrowers”), the lenders from time to time party thereto, and Credit Suisse AG, Cayman Islands Branch, as administrative agent for the lenders (in such capacity, the “Administrative Agent”) entered into a Fourth Amended and Restated First Lien Credit Agreement as amended by that certain Amendment No. 1 to Fourth Amended and Restated First Lien Credit Agreement dated as of July 1, 2022 (the "Amendment") (as so amended, the “Credit Agreement”). Pursuant to the Amendment, Elkay joined the Credit Agreement as a borrower (Elkay and the Original Borrowers, collectively, the "Borrowers"). The Credit Agreement is funded by a syndicate of banks and other financial institutions and provides for (i) a $ 550.0 million term loan facility (the “Term Loan”) and (ii) a $ 200.0 million revolving credit facility (the “Revolving Credit Facility”). </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The Credit Agreement provides for the issuance of a term loan facility in an aggregate principal amount of $ 550.0 million. The proceeds of the Term Loan were, together with the dividend received by the Company in connection with the Spin-Off Transaction and cash on hand, used to (i) repay in full the aggregate principal amount outstanding of the Prior Term Loan, together with accrued interest thereon, (ii) redeem the $ 500 million of outstanding principal amount of the 4.875 % Senior Notes due 2025, and (iii) pay related fees and expenses. | text | 550.0 | monetaryItemType | text: <entity> 550.0 </entity> <entity type> monetaryItemType </entity type> <context> The Credit Agreement provides for the issuance of a term loan facility in an aggregate principal amount of $ 550.0 million. The proceeds of the Term Loan were, together with the dividend received by the Company in connection with the Spin-Off Transaction and cash on hand, used to (i) repay in full the aggregate principal amount outstanding of the Prior Term Loan, together with accrued interest thereon, (ii) redeem the $ 500 million of outstanding principal amount of the 4.875 % Senior Notes due 2025, and (iii) pay related fees and expenses. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The Credit Agreement provides for the issuance of a term loan facility in an aggregate principal amount of $ 550.0 million. The proceeds of the Term Loan were, together with the dividend received by the Company in connection with the Spin-Off Transaction and cash on hand, used to (i) repay in full the aggregate principal amount outstanding of the Prior Term Loan, together with accrued interest thereon, (ii) redeem the $ 500 million of outstanding principal amount of the 4.875 % Senior Notes due 2025, and (iii) pay related fees and expenses. | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> The Credit Agreement provides for the issuance of a term loan facility in an aggregate principal amount of $ 550.0 million. The proceeds of the Term Loan were, together with the dividend received by the Company in connection with the Spin-Off Transaction and cash on hand, used to (i) repay in full the aggregate principal amount outstanding of the Prior Term Loan, together with accrued interest thereon, (ii) redeem the $ 500 million of outstanding principal amount of the 4.875 % Senior Notes due 2025, and (iii) pay related fees and expenses. </context> | us-gaap:RepaymentsOfDebt |
The Credit Agreement provides for the issuance of a term loan facility in an aggregate principal amount of $ 550.0 million. The proceeds of the Term Loan were, together with the dividend received by the Company in connection with the Spin-Off Transaction and cash on hand, used to (i) repay in full the aggregate principal amount outstanding of the Prior Term Loan, together with accrued interest thereon, (ii) redeem the $ 500 million of outstanding principal amount of the 4.875 % Senior Notes due 2025, and (iii) pay related fees and expenses. | text | 4.875 | percentItemType | text: <entity> 4.875 </entity> <entity type> percentItemType </entity type> <context> The Credit Agreement provides for the issuance of a term loan facility in an aggregate principal amount of $ 550.0 million. The proceeds of the Term Loan were, together with the dividend received by the Company in connection with the Spin-Off Transaction and cash on hand, used to (i) repay in full the aggregate principal amount outstanding of the Prior Term Loan, together with accrued interest thereon, (ii) redeem the $ 500 million of outstanding principal amount of the 4.875 % Senior Notes due 2025, and (iii) pay related fees and expenses. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On October 11, 2023, the Company made a voluntary prepayment on its Term Loan of $ 60.0 million. In connection with this prepayment, the Company recognized a $ 0.9 million loss on debt extinguishment to write off a portion of the unamortized debt issuance costs. | text | 60.0 | monetaryItemType | text: <entity> 60.0 </entity> <entity type> monetaryItemType </entity type> <context> On October 11, 2023, the Company made a voluntary prepayment on its Term Loan of $ 60.0 million. In connection with this prepayment, the Company recognized a $ 0.9 million loss on debt extinguishment to write off a portion of the unamortized debt issuance costs. </context> | us-gaap:RepaymentsOfDebt |
On October 11, 2023, the Company made a voluntary prepayment on its Term Loan of $ 60.0 million. In connection with this prepayment, the Company recognized a $ 0.9 million loss on debt extinguishment to write off a portion of the unamortized debt issuance costs. | text | 0.9 | monetaryItemType | text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> On October 11, 2023, the Company made a voluntary prepayment on its Term Loan of $ 60.0 million. In connection with this prepayment, the Company recognized a $ 0.9 million loss on debt extinguishment to write off a portion of the unamortized debt issuance costs. </context> | us-gaap:GainsLossesOnExtinguishmentOfDebt |
The Term Loan has a maturity date of October 4, 2028. Commencing on March 31, 2022, the Borrowers were required to make quarterly payments of principal in an amount equal to $ 1.4 million each quarter until the maturity date. In connection with the voluntary prepayment of $ 60.0 million, the quarterly principal payments of $ 1.4 million are no longer required. | text | 1.4 | monetaryItemType | text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> The Term Loan has a maturity date of October 4, 2028. Commencing on March 31, 2022, the Borrowers were required to make quarterly payments of principal in an amount equal to $ 1.4 million each quarter until the maturity date. In connection with the voluntary prepayment of $ 60.0 million, the quarterly principal payments of $ 1.4 million are no longer required. </context> | us-gaap:DebtInstrumentPeriodicPayment |
The Term Loan has a maturity date of October 4, 2028. Commencing on March 31, 2022, the Borrowers were required to make quarterly payments of principal in an amount equal to $ 1.4 million each quarter until the maturity date. In connection with the voluntary prepayment of $ 60.0 million, the quarterly principal payments of $ 1.4 million are no longer required. | text | 60.0 | monetaryItemType | text: <entity> 60.0 </entity> <entity type> monetaryItemType </entity type> <context> The Term Loan has a maturity date of October 4, 2028. Commencing on March 31, 2022, the Borrowers were required to make quarterly payments of principal in an amount equal to $ 1.4 million each quarter until the maturity date. In connection with the voluntary prepayment of $ 60.0 million, the quarterly principal payments of $ 1.4 million are no longer required. </context> | us-gaap:RepaymentsOfDebt |
For purposes of the Term Loan, effective July 1, 2023, the secured overnight financing rate ("SOFR") replaced LIBOR, and accordingly, beginning July 1, 2023 the Term Loan bears interest at the Borrowers' option, by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 1.80 to 1.00, the applicable margin shall equal 1.25 % in the case of base rate borrowings and 2.25 % in the case of SOFR borrowings. In the event the Borrowers’ Net First Lien Leverage Ratio is less than or equal to 1.80 to 1.00, the applicable margin on both base rate and | text | 0.115 | percentItemType | text: <entity> 0.115 </entity> <entity type> percentItemType </entity type> <context> For purposes of the Term Loan, effective July 1, 2023, the secured overnight financing rate ("SOFR") replaced LIBOR, and accordingly, beginning July 1, 2023 the Term Loan bears interest at the Borrowers' option, by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 1.80 to 1.00, the applicable margin shall equal 1.25 % in the case of base rate borrowings and 2.25 % in the case of SOFR borrowings. In the event the Borrowers’ Net First Lien Leverage Ratio is less than or equal to 1.80 to 1.00, the applicable margin on both base rate and </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
For purposes of the Term Loan, effective July 1, 2023, the secured overnight financing rate ("SOFR") replaced LIBOR, and accordingly, beginning July 1, 2023 the Term Loan bears interest at the Borrowers' option, by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 1.80 to 1.00, the applicable margin shall equal 1.25 % in the case of base rate borrowings and 2.25 % in the case of SOFR borrowings. In the event the Borrowers’ Net First Lien Leverage Ratio is less than or equal to 1.80 to 1.00, the applicable margin on both base rate and | text | 0.262 | percentItemType | text: <entity> 0.262 </entity> <entity type> percentItemType </entity type> <context> For purposes of the Term Loan, effective July 1, 2023, the secured overnight financing rate ("SOFR") replaced LIBOR, and accordingly, beginning July 1, 2023 the Term Loan bears interest at the Borrowers' option, by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 1.80 to 1.00, the applicable margin shall equal 1.25 % in the case of base rate borrowings and 2.25 % in the case of SOFR borrowings. In the event the Borrowers’ Net First Lien Leverage Ratio is less than or equal to 1.80 to 1.00, the applicable margin on both base rate and </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
For purposes of the Term Loan, effective July 1, 2023, the secured overnight financing rate ("SOFR") replaced LIBOR, and accordingly, beginning July 1, 2023 the Term Loan bears interest at the Borrowers' option, by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 1.80 to 1.00, the applicable margin shall equal 1.25 % in the case of base rate borrowings and 2.25 % in the case of SOFR borrowings. In the event the Borrowers’ Net First Lien Leverage Ratio is less than or equal to 1.80 to 1.00, the applicable margin on both base rate and | text | 0.428 | percentItemType | text: <entity> 0.428 </entity> <entity type> percentItemType </entity type> <context> For purposes of the Term Loan, effective July 1, 2023, the secured overnight financing rate ("SOFR") replaced LIBOR, and accordingly, beginning July 1, 2023 the Term Loan bears interest at the Borrowers' option, by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 1.80 to 1.00, the applicable margin shall equal 1.25 % in the case of base rate borrowings and 2.25 % in the case of SOFR borrowings. In the event the Borrowers’ Net First Lien Leverage Ratio is less than or equal to 1.80 to 1.00, the applicable margin on both base rate and </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
For purposes of the Term Loan, effective July 1, 2023, the secured overnight financing rate ("SOFR") replaced LIBOR, and accordingly, beginning July 1, 2023 the Term Loan bears interest at the Borrowers' option, by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 1.80 to 1.00, the applicable margin shall equal 1.25 % in the case of base rate borrowings and 2.25 % in the case of SOFR borrowings. In the event the Borrowers’ Net First Lien Leverage Ratio is less than or equal to 1.80 to 1.00, the applicable margin on both base rate and | text | 1.25 | percentItemType | text: <entity> 1.25 </entity> <entity type> percentItemType </entity type> <context> For purposes of the Term Loan, effective July 1, 2023, the secured overnight financing rate ("SOFR") replaced LIBOR, and accordingly, beginning July 1, 2023 the Term Loan bears interest at the Borrowers' option, by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 1.80 to 1.00, the applicable margin shall equal 1.25 % in the case of base rate borrowings and 2.25 % in the case of SOFR borrowings. In the event the Borrowers’ Net First Lien Leverage Ratio is less than or equal to 1.80 to 1.00, the applicable margin on both base rate and </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
For purposes of the Term Loan, effective July 1, 2023, the secured overnight financing rate ("SOFR") replaced LIBOR, and accordingly, beginning July 1, 2023 the Term Loan bears interest at the Borrowers' option, by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 1.80 to 1.00, the applicable margin shall equal 1.25 % in the case of base rate borrowings and 2.25 % in the case of SOFR borrowings. In the event the Borrowers’ Net First Lien Leverage Ratio is less than or equal to 1.80 to 1.00, the applicable margin on both base rate and | text | 2.25 | percentItemType | text: <entity> 2.25 </entity> <entity type> percentItemType </entity type> <context> For purposes of the Term Loan, effective July 1, 2023, the secured overnight financing rate ("SOFR") replaced LIBOR, and accordingly, beginning July 1, 2023 the Term Loan bears interest at the Borrowers' option, by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 1.80 to 1.00, the applicable margin shall equal 1.25 % in the case of base rate borrowings and 2.25 % in the case of SOFR borrowings. In the event the Borrowers’ Net First Lien Leverage Ratio is less than or equal to 1.80 to 1.00, the applicable margin on both base rate and </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024 and therefore the applicable rate is 2.00 %. | text | 0.25 | percentItemType | text: <entity> 0.25 </entity> <entity type> percentItemType </entity type> <context> SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024 and therefore the applicable rate is 2.00 %. </context> | us-gaap:DebtInstrumentInterestRateIncreaseDecrease |
SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024 and therefore the applicable rate is 2.00 %. | text | 2.00 | percentItemType | text: <entity> 2.00 </entity> <entity type> percentItemType </entity type> <context> SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024 and therefore the applicable rate is 2.00 %. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
At December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 6.42 % and 7.47 %, respectively. During the year ended December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 7.28 % and 7.09 %, respectively. | text | 6.42 | percentItemType | text: <entity> 6.42 </entity> <entity type> percentItemType </entity type> <context> At December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 6.42 % and 7.47 %, respectively. During the year ended December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 7.28 % and 7.09 %, respectively. </context> | us-gaap:DebtWeightedAverageInterestRate |
At December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 6.42 % and 7.47 %, respectively. During the year ended December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 7.28 % and 7.09 %, respectively. | text | 7.47 | percentItemType | text: <entity> 7.47 </entity> <entity type> percentItemType </entity type> <context> At December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 6.42 % and 7.47 %, respectively. During the year ended December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 7.28 % and 7.09 %, respectively. </context> | us-gaap:DebtWeightedAverageInterestRate |
At December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 6.42 % and 7.47 %, respectively. During the year ended December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 7.28 % and 7.09 %, respectively. | text | 7.28 | percentItemType | text: <entity> 7.28 </entity> <entity type> percentItemType </entity type> <context> At December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 6.42 % and 7.47 %, respectively. During the year ended December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 7.28 % and 7.09 %, respectively. </context> | us-gaap:LongTermDebtWeightedAverageInterestRateOverTime |
At December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 6.42 % and 7.47 %, respectively. During the year ended December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 7.28 % and 7.09 %, respectively. | text | 7.09 | percentItemType | text: <entity> 7.09 </entity> <entity type> percentItemType </entity type> <context> At December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 6.42 % and 7.47 %, respectively. During the year ended December 31, 2024 and December 31, 2023, the borrowings under the Term Loan had weighted-average effective interest rates of 7.28 % and 7.09 %, respectively. </context> | us-gaap:LongTermDebtWeightedAverageInterestRateOverTime |
The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. | text | 200.0 | monetaryItemType | text: <entity> 200.0 </entity> <entity type> monetaryItemType </entity type> <context> The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. | text | 0.115 | percentItemType | text: <entity> 0.115 </entity> <entity type> percentItemType </entity type> <context> The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. | text | 0.262 | percentItemType | text: <entity> 0.262 </entity> <entity type> percentItemType </entity type> <context> The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. | text | 0.428 | percentItemType | text: <entity> 0.428 </entity> <entity type> percentItemType </entity type> <context> The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. | text | 1.00 | percentItemType | text: <entity> 1.00 </entity> <entity type> percentItemType </entity type> <context> The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. | text | 2.00 | percentItemType | text: <entity> 2.00 </entity> <entity type> percentItemType </entity type> <context> The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. | text | 0.25 | percentItemType | text: <entity> 0.25 </entity> <entity type> percentItemType </entity type> <context> The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. </context> | us-gaap:DebtInstrumentInterestRateIncreaseDecrease |
The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. | text | 0.50 | percentItemType | text: <entity> 0.50 </entity> <entity type> percentItemType </entity type> <context> The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. </context> | us-gaap:LineOfCreditFacilityCommitmentFeePercentage |
The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. | text | 0.375 | percentItemType | text: <entity> 0.375 </entity> <entity type> percentItemType </entity type> <context> The Credit Agreement includes a $ 200.0 million revolving credit facility that has a maturity date of October 2, 2026. Similar to the Term Loan, effective July 1, 2023, the SOFR replaced LIBOR, and accordingly, beginning July 1, 2023 the Revolving Credit Facility bears interest by reference to a base rate or a rate based on Term SOFR, plus a Term SOFR adjustment of 0.115 %, 0.262 %, or 0.428 % for interest periods of one month, three months, and six months, respectively, plus an applicable margin based on the Borrowers' Net First Lien Leverage Ratio as of the last day of each fiscal quarter. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the applicable margin shall equal 1.00 % in the case of base rate borrowings and 2.00 % in the case of SOFR borrowings. In the event the Borrowers' Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the applicable margin on both base rate and SOFR borrowings would decrease by 0.25 %. The Borrowers’ Net First Lien Leverage Ratio was 0.86 to 1.00 as of December 31, 2024. The Borrowers are also required to pay a quarterly commitment fee on the average daily unused portion of the Revolving Credit Facility for each fiscal quarter and fees in connection with the issuance of letters of credit. If the Net First Lien Leverage Ratio is greater than 2.00 to 1.00, the commitment fee is 0.50 %, and if the Company's Net First Lien Leverage Ratio is less than or equal to 2.00 to 1.00, the commitment fee is 0.375 %. </context> | us-gaap:LineOfCreditFacilityCommitmentFeePercentage |
At December 31, 2024 and December 31, 2023, there were no amounts borrowed under the Revolving Credit Facility. As of December 31, 2024 and December 31, 2023, $ 11.3 million and $ 11.0 million of the Revolving Credit Facility was considered utilized in connection with outstanding letters of credit, respectively. | text | 11.3 | monetaryItemType | text: <entity> 11.3 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024 and December 31, 2023, there were no amounts borrowed under the Revolving Credit Facility. As of December 31, 2024 and December 31, 2023, $ 11.3 million and $ 11.0 million of the Revolving Credit Facility was considered utilized in connection with outstanding letters of credit, respectively. </context> | us-gaap:LettersOfCreditOutstandingAmount |
At December 31, 2024 and December 31, 2023, there were no amounts borrowed under the Revolving Credit Facility. As of December 31, 2024 and December 31, 2023, $ 11.3 million and $ 11.0 million of the Revolving Credit Facility was considered utilized in connection with outstanding letters of credit, respectively. | text | 11.0 | monetaryItemType | text: <entity> 11.0 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024 and December 31, 2023, there were no amounts borrowed under the Revolving Credit Facility. As of December 31, 2024 and December 31, 2023, $ 11.3 million and $ 11.0 million of the Revolving Credit Facility was considered utilized in connection with outstanding letters of credit, respectively. </context> | us-gaap:LettersOfCreditOutstandingAmount |
At December 31, 2024 and 2023, the Company had finance lease obligations of $ 20.6 million and $ 21.7 million, respectively. For more information related to finance leases, see Note 13, Leases. | text | 20.6 | monetaryItemType | text: <entity> 20.6 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024 and 2023, the Company had finance lease obligations of $ 20.6 million and $ 21.7 million, respectively. For more information related to finance leases, see Note 13, Leases. </context> | us-gaap:LongTermDebt |
At December 31, 2024 and 2023, the Company had finance lease obligations of $ 20.6 million and $ 21.7 million, respectively. For more information related to finance leases, see Note 13, Leases. | text | 21.7 | monetaryItemType | text: <entity> 21.7 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024 and 2023, the Company had finance lease obligations of $ 20.6 million and $ 21.7 million, respectively. For more information related to finance leases, see Note 13, Leases. </context> | us-gaap:LongTermDebt |
Future maturities of debt and finance lease obligations as of December 31, 2024, excluding the unamortized debt issuance costs of $ 5.4 million, were as follows (in millions): | text | 5.4 | monetaryItemType | text: <entity> 5.4 </entity> <entity type> monetaryItemType </entity type> <context> Future maturities of debt and finance lease obligations as of December 31, 2024, excluding the unamortized debt issuance costs of $ 5.4 million, were as follows (in millions): </context> | us-gaap:DebtInstrumentUnamortizedDiscount |
In May 2024, the Company’s stockholders approved the adoption of the Zurn Elkay Water Solutions Corporation Employee Stock Purchase Plan (“ESPP"). The number of shares of Company common stock available for purchase under the ESPP is 2,000,000 shares, subject to adjustment in the event of a change in capitalization. | text | 2000000 | sharesItemType | text: <entity> 2000000 </entity> <entity type> sharesItemType </entity type> <context> In May 2024, the Company’s stockholders approved the adoption of the Zurn Elkay Water Solutions Corporation Employee Stock Purchase Plan (“ESPP"). The number of shares of Company common stock available for purchase under the ESPP is 2,000,000 shares, subject to adjustment in the event of a change in capitalization. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
During the year ended December 31, 2024, the Company issued 44,436 shares of common stock related to the ESPP. As of December 31, 2024, 1,955,564 shares remained available for future issuance. During the year ended December 31, 2024, the Company recognized $ 0.3 million of stock-based compensation expense related to the ESPP. | text | 44436 | sharesItemType | text: <entity> 44436 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2024, the Company issued 44,436 shares of common stock related to the ESPP. As of December 31, 2024, 1,955,564 shares remained available for future issuance. During the year ended December 31, 2024, the Company recognized $ 0.3 million of stock-based compensation expense related to the ESPP. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod |
During the year ended December 31, 2024, the Company issued 44,436 shares of common stock related to the ESPP. As of December 31, 2024, 1,955,564 shares remained available for future issuance. During the year ended December 31, 2024, the Company recognized $ 0.3 million of stock-based compensation expense related to the ESPP. | text | 1955564 | sharesItemType | text: <entity> 1955564 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2024, the Company issued 44,436 shares of common stock related to the ESPP. As of December 31, 2024, 1,955,564 shares remained available for future issuance. During the year ended December 31, 2024, the Company recognized $ 0.3 million of stock-based compensation expense related to the ESPP. </context> | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
During the year ended December 31, 2024, the Company issued 44,436 shares of common stock related to the ESPP. As of December 31, 2024, 1,955,564 shares remained available for future issuance. During the year ended December 31, 2024, the Company recognized $ 0.3 million of stock-based compensation expense related to the ESPP. | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company issued 44,436 shares of common stock related to the ESPP. As of December 31, 2024, 1,955,564 shares remained available for future issuance. During the year ended December 31, 2024, the Company recognized $ 0.3 million of stock-based compensation expense related to the ESPP. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
the awards and resulted in approximately $ 4.9 million of incremental expense, of which $ 0.2 million and $ 0.2 million was recognized during the years ended December 31, 2023 and 2022, respectively. On the date of the Spin-Off Transaction, the modification affected 124 grantees. | text | 0.2 | monetaryItemType | text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> the awards and resulted in approximately $ 4.9 million of incremental expense, of which $ 0.2 million and $ 0.2 million was recognized during the years ended December 31, 2023 and 2022, respectively. On the date of the Spin-Off Transaction, the modification affected 124 grantees. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
the awards and resulted in approximately $ 4.9 million of incremental expense, of which $ 0.2 million and $ 0.2 million was recognized during the years ended December 31, 2023 and 2022, respectively. On the date of the Spin-Off Transaction, the modification affected 124 grantees. | text | 124 | integerItemType | text: <entity> 124 </entity> <entity type> integerItemType </entity type> <context> the awards and resulted in approximately $ 4.9 million of incremental expense, of which $ 0.2 million and $ 0.2 million was recognized during the years ended December 31, 2023 and 2022, respectively. On the date of the Spin-Off Transaction, the modification affected 124 grantees. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationNumberOfEmployeesAffected |
During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. | text | 37.9 | monetaryItemType | text: <entity> 37.9 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. | text | 40.0 | monetaryItemType | text: <entity> 40.0 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. | text | 25.0 | monetaryItemType | text: <entity> 25.0 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. | text | 9.2 | monetaryItemType | text: <entity> 9.2 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. | text | 9.8 | monetaryItemType | text: <entity> 9.8 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. | text | 5.9 | monetaryItemType | text: <entity> 5.9 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. | text | 4.6 | monetaryItemType | text: <entity> 4.6 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions |
During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. | text | 2.0 | monetaryItemType | text: <entity> 2.0 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions |
During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. | text | 0.9 | monetaryItemType | text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions |
During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. | text | 31.7 | monetaryItemType | text: <entity> 31.7 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, the Company recorded $ 37.9 million, $ 40.0 million and $ 25.0 million, respectively, of stock-based compensation expense from continuing operations (the related tax benefit on these amounts subject to the 162(m) compensation limitations during the years ended December 31, 2024, 2023, and 2022 was $ 9.2 million, $ 9.8 million, and $ 5.9 million, respectively). During the year ended December 31, 2024, 2023, and 2022, the Company also recorded $ 4.6 million, $ 2.0 million and $ 0.9 million, respectively, of an excess tax benefit related to stock options exercised during each period. As of December 31, 2024, there was $ 31.7 million of total unrecognized compensation cost related to non-vested stock options, RSUs and PSUs granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.7 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
Management’s estimate of the option term for options granted under the Plan is based on the midpoint between when the options vest and when they expire. The Company uses the simplified method to determine the expected term, as management does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The Company’s expected volatility assumption for all options granted prior to the Spin-Off Transaction is based on the historical volatility of the Company's common stock price. The expected volatility assumption for all options granted after the Spin-Off Transaction is based on the historical volatility of the common stock prices of a peer group. The weighted average risk free interest rate is based on the U.S. Treasury yield curve in effect at the date of grant. The weighted-average grant date fair value of options granted under the Plan during the years ended December 31, 2024, 2023, and 2022 was $ 11.43 , $ 8.28 and $ 9.79 , respectively. The total fair value of options vested during the years ended December 31, 2024, 2023, and 2022 was $ 1.1 million, $ 0.9 million and $ 0.9 million, respectively. | text | 11.43 | perShareItemType | text: <entity> 11.43 </entity> <entity type> perShareItemType </entity type> <context> Management’s estimate of the option term for options granted under the Plan is based on the midpoint between when the options vest and when they expire. The Company uses the simplified method to determine the expected term, as management does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The Company’s expected volatility assumption for all options granted prior to the Spin-Off Transaction is based on the historical volatility of the Company's common stock price. The expected volatility assumption for all options granted after the Spin-Off Transaction is based on the historical volatility of the common stock prices of a peer group. The weighted average risk free interest rate is based on the U.S. Treasury yield curve in effect at the date of grant. The weighted-average grant date fair value of options granted under the Plan during the years ended December 31, 2024, 2023, and 2022 was $ 11.43 , $ 8.28 and $ 9.79 , respectively. The total fair value of options vested during the years ended December 31, 2024, 2023, and 2022 was $ 1.1 million, $ 0.9 million and $ 0.9 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
Management’s estimate of the option term for options granted under the Plan is based on the midpoint between when the options vest and when they expire. The Company uses the simplified method to determine the expected term, as management does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The Company’s expected volatility assumption for all options granted prior to the Spin-Off Transaction is based on the historical volatility of the Company's common stock price. The expected volatility assumption for all options granted after the Spin-Off Transaction is based on the historical volatility of the common stock prices of a peer group. The weighted average risk free interest rate is based on the U.S. Treasury yield curve in effect at the date of grant. The weighted-average grant date fair value of options granted under the Plan during the years ended December 31, 2024, 2023, and 2022 was $ 11.43 , $ 8.28 and $ 9.79 , respectively. The total fair value of options vested during the years ended December 31, 2024, 2023, and 2022 was $ 1.1 million, $ 0.9 million and $ 0.9 million, respectively. | text | 8.28 | perShareItemType | text: <entity> 8.28 </entity> <entity type> perShareItemType </entity type> <context> Management’s estimate of the option term for options granted under the Plan is based on the midpoint between when the options vest and when they expire. The Company uses the simplified method to determine the expected term, as management does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The Company’s expected volatility assumption for all options granted prior to the Spin-Off Transaction is based on the historical volatility of the Company's common stock price. The expected volatility assumption for all options granted after the Spin-Off Transaction is based on the historical volatility of the common stock prices of a peer group. The weighted average risk free interest rate is based on the U.S. Treasury yield curve in effect at the date of grant. The weighted-average grant date fair value of options granted under the Plan during the years ended December 31, 2024, 2023, and 2022 was $ 11.43 , $ 8.28 and $ 9.79 , respectively. The total fair value of options vested during the years ended December 31, 2024, 2023, and 2022 was $ 1.1 million, $ 0.9 million and $ 0.9 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
Management’s estimate of the option term for options granted under the Plan is based on the midpoint between when the options vest and when they expire. The Company uses the simplified method to determine the expected term, as management does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The Company’s expected volatility assumption for all options granted prior to the Spin-Off Transaction is based on the historical volatility of the Company's common stock price. The expected volatility assumption for all options granted after the Spin-Off Transaction is based on the historical volatility of the common stock prices of a peer group. The weighted average risk free interest rate is based on the U.S. Treasury yield curve in effect at the date of grant. The weighted-average grant date fair value of options granted under the Plan during the years ended December 31, 2024, 2023, and 2022 was $ 11.43 , $ 8.28 and $ 9.79 , respectively. The total fair value of options vested during the years ended December 31, 2024, 2023, and 2022 was $ 1.1 million, $ 0.9 million and $ 0.9 million, respectively. | text | 9.79 | perShareItemType | text: <entity> 9.79 </entity> <entity type> perShareItemType </entity type> <context> Management’s estimate of the option term for options granted under the Plan is based on the midpoint between when the options vest and when they expire. The Company uses the simplified method to determine the expected term, as management does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The Company’s expected volatility assumption for all options granted prior to the Spin-Off Transaction is based on the historical volatility of the Company's common stock price. The expected volatility assumption for all options granted after the Spin-Off Transaction is based on the historical volatility of the common stock prices of a peer group. The weighted average risk free interest rate is based on the U.S. Treasury yield curve in effect at the date of grant. The weighted-average grant date fair value of options granted under the Plan during the years ended December 31, 2024, 2023, and 2022 was $ 11.43 , $ 8.28 and $ 9.79 , respectively. The total fair value of options vested during the years ended December 31, 2024, 2023, and 2022 was $ 1.1 million, $ 0.9 million and $ 0.9 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
Management’s estimate of the option term for options granted under the Plan is based on the midpoint between when the options vest and when they expire. The Company uses the simplified method to determine the expected term, as management does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The Company’s expected volatility assumption for all options granted prior to the Spin-Off Transaction is based on the historical volatility of the Company's common stock price. The expected volatility assumption for all options granted after the Spin-Off Transaction is based on the historical volatility of the common stock prices of a peer group. The weighted average risk free interest rate is based on the U.S. Treasury yield curve in effect at the date of grant. The weighted-average grant date fair value of options granted under the Plan during the years ended December 31, 2024, 2023, and 2022 was $ 11.43 , $ 8.28 and $ 9.79 , respectively. The total fair value of options vested during the years ended December 31, 2024, 2023, and 2022 was $ 1.1 million, $ 0.9 million and $ 0.9 million, respectively. | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> Management’s estimate of the option term for options granted under the Plan is based on the midpoint between when the options vest and when they expire. The Company uses the simplified method to determine the expected term, as management does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The Company’s expected volatility assumption for all options granted prior to the Spin-Off Transaction is based on the historical volatility of the Company's common stock price. The expected volatility assumption for all options granted after the Spin-Off Transaction is based on the historical volatility of the common stock prices of a peer group. The weighted average risk free interest rate is based on the U.S. Treasury yield curve in effect at the date of grant. The weighted-average grant date fair value of options granted under the Plan during the years ended December 31, 2024, 2023, and 2022 was $ 11.43 , $ 8.28 and $ 9.79 , respectively. The total fair value of options vested during the years ended December 31, 2024, 2023, and 2022 was $ 1.1 million, $ 0.9 million and $ 0.9 million, respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
Management’s estimate of the option term for options granted under the Plan is based on the midpoint between when the options vest and when they expire. The Company uses the simplified method to determine the expected term, as management does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The Company’s expected volatility assumption for all options granted prior to the Spin-Off Transaction is based on the historical volatility of the Company's common stock price. The expected volatility assumption for all options granted after the Spin-Off Transaction is based on the historical volatility of the common stock prices of a peer group. The weighted average risk free interest rate is based on the U.S. Treasury yield curve in effect at the date of grant. The weighted-average grant date fair value of options granted under the Plan during the years ended December 31, 2024, 2023, and 2022 was $ 11.43 , $ 8.28 and $ 9.79 , respectively. The total fair value of options vested during the years ended December 31, 2024, 2023, and 2022 was $ 1.1 million, $ 0.9 million and $ 0.9 million, respectively. | text | 0.9 | monetaryItemType | text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> Management’s estimate of the option term for options granted under the Plan is based on the midpoint between when the options vest and when they expire. The Company uses the simplified method to determine the expected term, as management does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The Company’s expected volatility assumption for all options granted prior to the Spin-Off Transaction is based on the historical volatility of the Company's common stock price. The expected volatility assumption for all options granted after the Spin-Off Transaction is based on the historical volatility of the common stock prices of a peer group. The weighted average risk free interest rate is based on the U.S. Treasury yield curve in effect at the date of grant. The weighted-average grant date fair value of options granted under the Plan during the years ended December 31, 2024, 2023, and 2022 was $ 11.43 , $ 8.28 and $ 9.79 , respectively. The total fair value of options vested during the years ended December 31, 2024, 2023, and 2022 was $ 1.1 million, $ 0.9 million and $ 0.9 million, respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
, and 2022 was $ 29.3 million, $ 11.0 million and $ 3.8 million, respectively. | text | 29.3 | monetaryItemType | text: <entity> 29.3 </entity> <entity type> monetaryItemType </entity type> <context> , and 2022 was $ 29.3 million, $ 11.0 million and $ 3.8 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
, and 2022 was $ 29.3 million, $ 11.0 million and $ 3.8 million, respectively. | text | 11.0 | monetaryItemType | text: <entity> 11.0 </entity> <entity type> monetaryItemType </entity type> <context> , and 2022 was $ 29.3 million, $ 11.0 million and $ 3.8 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
, and 2022 was $ 29.3 million, $ 11.0 million and $ 3.8 million, respectively. | text | 3.8 | monetaryItemType | text: <entity> 3.8 </entity> <entity type> monetaryItemType </entity type> <context> , and 2022 was $ 29.3 million, $ 11.0 million and $ 3.8 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The weighted average remaining contractual life of options outstanding was 4.8 years at December 31, 2024, 4.1 years at December 31, 2023 and 4.4 years at December 31, 2022. The aggregate intrinsic value of options outstanding at December 31, 2024 was $ 17.0 million. | text | 17.0 | monetaryItemType | text: <entity> 17.0 </entity> <entity type> monetaryItemType </entity type> <context> The weighted average remaining contractual life of options outstanding was 4.8 years at December 31, 2024, 4.1 years at December 31, 2023 and 4.4 years at December 31, 2022. The aggregate intrinsic value of options outstanding at December 31, 2024 was $ 17.0 million. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue |
The weighted average remaining contractual life of options exercisable was 3.9 years at December 31, 2024, 3.4 years at December 31, 2023 and 3.9 years at December 31, 2022. The aggregate intrinsic value of options exercisable at December 31, 2024 was $ 15.4 million. | text | 15.4 | monetaryItemType | text: <entity> 15.4 </entity> <entity type> monetaryItemType </entity type> <context> The weighted average remaining contractual life of options exercisable was 3.9 years at December 31, 2024, 3.4 years at December 31, 2023 and 3.9 years at December 31, 2022. The aggregate intrinsic value of options exercisable at December 31, 2024 was $ 15.4 million. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 |
During the years ended December 31, 2024, 2023, and 2022, the Company granted PSUs to certain of its officers and employees. The PSUs granted during the years ended December 31, 2024 and 2023 had a three-year performance period, while the PSUs granted during the year ended December 31, 2022 had a two-and-a-half-year performance period, and are earned and vest, subject to continued employment, based on performance relative to metrics determined by the Compensation Committee. The number of performance share awards earned, which can range between 0 % and 200 % of the target awards granted depending on the Company's actual performance during the respective performance period, will be satisfied with Zurn Elkay common stock. A summary of PSU activity during the years ended December 31, 2024, 2023, and 2022 is as follows: | text | 0 | percentItemType | text: <entity> 0 </entity> <entity type> percentItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, the Company granted PSUs to certain of its officers and employees. The PSUs granted during the years ended December 31, 2024 and 2023 had a three-year performance period, while the PSUs granted during the year ended December 31, 2022 had a two-and-a-half-year performance period, and are earned and vest, subject to continued employment, based on performance relative to metrics determined by the Compensation Committee. The number of performance share awards earned, which can range between 0 % and 200 % of the target awards granted depending on the Company's actual performance during the respective performance period, will be satisfied with Zurn Elkay common stock. A summary of PSU activity during the years ended December 31, 2024, 2023, and 2022 is as follows: </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
During the years ended December 31, 2024, 2023, and 2022, the Company granted PSUs to certain of its officers and employees. The PSUs granted during the years ended December 31, 2024 and 2023 had a three-year performance period, while the PSUs granted during the year ended December 31, 2022 had a two-and-a-half-year performance period, and are earned and vest, subject to continued employment, based on performance relative to metrics determined by the Compensation Committee. The number of performance share awards earned, which can range between 0 % and 200 % of the target awards granted depending on the Company's actual performance during the respective performance period, will be satisfied with Zurn Elkay common stock. A summary of PSU activity during the years ended December 31, 2024, 2023, and 2022 is as follows: | text | 200 | percentItemType | text: <entity> 200 </entity> <entity type> percentItemType </entity type> <context> During the years ended December 31, 2024, 2023, and 2022, the Company granted PSUs to certain of its officers and employees. The PSUs granted during the years ended December 31, 2024 and 2023 had a three-year performance period, while the PSUs granted during the year ended December 31, 2022 had a two-and-a-half-year performance period, and are earned and vest, subject to continued employment, based on performance relative to metrics determined by the Compensation Committee. The number of performance share awards earned, which can range between 0 % and 200 % of the target awards granted depending on the Company's actual performance during the respective performance period, will be satisfied with Zurn Elkay common stock. A summary of PSU activity during the years ended December 31, 2024, 2023, and 2022 is as follows: </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
During the year ended December 31, 2024, the recognition of $ 1.4 million of net non-cash actuarial gains was primarily due to a combination of discount rate increases coupled with demographic and claims gains experienced during 2024 that were reflected in the other post-retirement benefit plans. These gains were partially offset by an increase in the medical cost growth assumption from the prior measurement. During the year ended December 31, 2023, the recognition of $ 2.0 million of net non-cash actuarial gains was primarily due to demographic gains experienced during 2023 that were reflected in the other post-retirement benefit plans. In addition, the post 65 medical provider options changed resulting in lower premiums for the plans. These gains were partially offset by a decrease in discount rate from the prior measurement. During the year ended December 31, 2022, the recognition of $ 1.9 million of net non-cash actuarial gains was primarily due to an increase in the discount rate utilized within remeasurement of the Company's defined benefit plans partially offset by unfavorable asset returns. | text | 1.4 | monetaryItemType | text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the recognition of $ 1.4 million of net non-cash actuarial gains was primarily due to a combination of discount rate increases coupled with demographic and claims gains experienced during 2024 that were reflected in the other post-retirement benefit plans. These gains were partially offset by an increase in the medical cost growth assumption from the prior measurement. During the year ended December 31, 2023, the recognition of $ 2.0 million of net non-cash actuarial gains was primarily due to demographic gains experienced during 2023 that were reflected in the other post-retirement benefit plans. In addition, the post 65 medical provider options changed resulting in lower premiums for the plans. These gains were partially offset by a decrease in discount rate from the prior measurement. During the year ended December 31, 2022, the recognition of $ 1.9 million of net non-cash actuarial gains was primarily due to an increase in the discount rate utilized within remeasurement of the Company's defined benefit plans partially offset by unfavorable asset returns. </context> | us-gaap:DefinedBenefitPlanActuarialGainLoss |
During the year ended December 31, 2024, the recognition of $ 1.4 million of net non-cash actuarial gains was primarily due to a combination of discount rate increases coupled with demographic and claims gains experienced during 2024 that were reflected in the other post-retirement benefit plans. These gains were partially offset by an increase in the medical cost growth assumption from the prior measurement. During the year ended December 31, 2023, the recognition of $ 2.0 million of net non-cash actuarial gains was primarily due to demographic gains experienced during 2023 that were reflected in the other post-retirement benefit plans. In addition, the post 65 medical provider options changed resulting in lower premiums for the plans. These gains were partially offset by a decrease in discount rate from the prior measurement. During the year ended December 31, 2022, the recognition of $ 1.9 million of net non-cash actuarial gains was primarily due to an increase in the discount rate utilized within remeasurement of the Company's defined benefit plans partially offset by unfavorable asset returns. | text | 2.0 | monetaryItemType | text: <entity> 2.0 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the recognition of $ 1.4 million of net non-cash actuarial gains was primarily due to a combination of discount rate increases coupled with demographic and claims gains experienced during 2024 that were reflected in the other post-retirement benefit plans. These gains were partially offset by an increase in the medical cost growth assumption from the prior measurement. During the year ended December 31, 2023, the recognition of $ 2.0 million of net non-cash actuarial gains was primarily due to demographic gains experienced during 2023 that were reflected in the other post-retirement benefit plans. In addition, the post 65 medical provider options changed resulting in lower premiums for the plans. These gains were partially offset by a decrease in discount rate from the prior measurement. During the year ended December 31, 2022, the recognition of $ 1.9 million of net non-cash actuarial gains was primarily due to an increase in the discount rate utilized within remeasurement of the Company's defined benefit plans partially offset by unfavorable asset returns. </context> | us-gaap:DefinedBenefitPlanActuarialGainLoss |
During the year ended December 31, 2024, the recognition of $ 1.4 million of net non-cash actuarial gains was primarily due to a combination of discount rate increases coupled with demographic and claims gains experienced during 2024 that were reflected in the other post-retirement benefit plans. These gains were partially offset by an increase in the medical cost growth assumption from the prior measurement. During the year ended December 31, 2023, the recognition of $ 2.0 million of net non-cash actuarial gains was primarily due to demographic gains experienced during 2023 that were reflected in the other post-retirement benefit plans. In addition, the post 65 medical provider options changed resulting in lower premiums for the plans. These gains were partially offset by a decrease in discount rate from the prior measurement. During the year ended December 31, 2022, the recognition of $ 1.9 million of net non-cash actuarial gains was primarily due to an increase in the discount rate utilized within remeasurement of the Company's defined benefit plans partially offset by unfavorable asset returns. | text | 1.9 | monetaryItemType | text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the recognition of $ 1.4 million of net non-cash actuarial gains was primarily due to a combination of discount rate increases coupled with demographic and claims gains experienced during 2024 that were reflected in the other post-retirement benefit plans. These gains were partially offset by an increase in the medical cost growth assumption from the prior measurement. During the year ended December 31, 2023, the recognition of $ 2.0 million of net non-cash actuarial gains was primarily due to demographic gains experienced during 2023 that were reflected in the other post-retirement benefit plans. In addition, the post 65 medical provider options changed resulting in lower premiums for the plans. These gains were partially offset by a decrease in discount rate from the prior measurement. During the year ended December 31, 2022, the recognition of $ 1.9 million of net non-cash actuarial gains was primarily due to an increase in the discount rate utilized within remeasurement of the Company's defined benefit plans partially offset by unfavorable asset returns. </context> | us-gaap:DefinedBenefitPlanActuarialGainLoss |
The Company made contributions to its U.S. qualified pension plan trusts of $ 20.0 million, $ 11.0 million and $ 0.3 million during the years ended December 31, 2024, 2023, and 2022, respectively. | text | 20.0 | monetaryItemType | text: <entity> 20.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company made contributions to its U.S. qualified pension plan trusts of $ 20.0 million, $ 11.0 million and $ 0.3 million during the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:DefinedBenefitPlanContributionsByEmployer |
The Company made contributions to its U.S. qualified pension plan trusts of $ 20.0 million, $ 11.0 million and $ 0.3 million during the years ended December 31, 2024, 2023, and 2022, respectively. | text | 11.0 | monetaryItemType | text: <entity> 11.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company made contributions to its U.S. qualified pension plan trusts of $ 20.0 million, $ 11.0 million and $ 0.3 million during the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:DefinedBenefitPlanContributionsByEmployer |
The Company made contributions to its U.S. qualified pension plan trusts of $ 20.0 million, $ 11.0 million and $ 0.3 million during the years ended December 31, 2024, 2023, and 2022, respectively. | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company made contributions to its U.S. qualified pension plan trusts of $ 20.0 million, $ 11.0 million and $ 0.3 million during the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:DefinedBenefitPlanContributionsByEmployer |
As of December 31, 2024, the Company had pension plans with a combined projected benefit obligation of $ 210.6 million compared to plan assets of $ 203.0 million, resulting in an under-funded status of $ 7.6 million compared to an under-funded status of $ 28.8 million at December 31, 2023. The Company’s funded status improved during the year ended December 31, 2024 primarily due to the $ 20.0 million pension plan contribution. Any further changes in the assumptions underlying the Company’s pension values, including those that arise as a result of declines in equity markets and changes in interest rates, could result in increased pension obligation and pension cost which could negatively affect the Company’s consolidated financial position and results of operations in future periods. | text | 210.6 | monetaryItemType | text: <entity> 210.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had pension plans with a combined projected benefit obligation of $ 210.6 million compared to plan assets of $ 203.0 million, resulting in an under-funded status of $ 7.6 million compared to an under-funded status of $ 28.8 million at December 31, 2023. The Company’s funded status improved during the year ended December 31, 2024 primarily due to the $ 20.0 million pension plan contribution. Any further changes in the assumptions underlying the Company’s pension values, including those that arise as a result of declines in equity markets and changes in interest rates, could result in increased pension obligation and pension cost which could negatively affect the Company’s consolidated financial position and results of operations in future periods. </context> | us-gaap:DefinedBenefitPlanBenefitObligation |
As of December 31, 2024, the Company had pension plans with a combined projected benefit obligation of $ 210.6 million compared to plan assets of $ 203.0 million, resulting in an under-funded status of $ 7.6 million compared to an under-funded status of $ 28.8 million at December 31, 2023. The Company’s funded status improved during the year ended December 31, 2024 primarily due to the $ 20.0 million pension plan contribution. Any further changes in the assumptions underlying the Company’s pension values, including those that arise as a result of declines in equity markets and changes in interest rates, could result in increased pension obligation and pension cost which could negatively affect the Company’s consolidated financial position and results of operations in future periods. | text | 203.0 | monetaryItemType | text: <entity> 203.0 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had pension plans with a combined projected benefit obligation of $ 210.6 million compared to plan assets of $ 203.0 million, resulting in an under-funded status of $ 7.6 million compared to an under-funded status of $ 28.8 million at December 31, 2023. The Company’s funded status improved during the year ended December 31, 2024 primarily due to the $ 20.0 million pension plan contribution. Any further changes in the assumptions underlying the Company’s pension values, including those that arise as a result of declines in equity markets and changes in interest rates, could result in increased pension obligation and pension cost which could negatively affect the Company’s consolidated financial position and results of operations in future periods. </context> | us-gaap:DefinedBenefitPlanFairValueOfPlanAssets |
As of December 31, 2024, the Company had pension plans with a combined projected benefit obligation of $ 210.6 million compared to plan assets of $ 203.0 million, resulting in an under-funded status of $ 7.6 million compared to an under-funded status of $ 28.8 million at December 31, 2023. The Company’s funded status improved during the year ended December 31, 2024 primarily due to the $ 20.0 million pension plan contribution. Any further changes in the assumptions underlying the Company’s pension values, including those that arise as a result of declines in equity markets and changes in interest rates, could result in increased pension obligation and pension cost which could negatively affect the Company’s consolidated financial position and results of operations in future periods. | text | 7.6 | monetaryItemType | text: <entity> 7.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had pension plans with a combined projected benefit obligation of $ 210.6 million compared to plan assets of $ 203.0 million, resulting in an under-funded status of $ 7.6 million compared to an under-funded status of $ 28.8 million at December 31, 2023. The Company’s funded status improved during the year ended December 31, 2024 primarily due to the $ 20.0 million pension plan contribution. Any further changes in the assumptions underlying the Company’s pension values, including those that arise as a result of declines in equity markets and changes in interest rates, could result in increased pension obligation and pension cost which could negatively affect the Company’s consolidated financial position and results of operations in future periods. </context> | us-gaap:DefinedBenefitPlanFundedStatusOfPlan |
As of December 31, 2024, the Company had pension plans with a combined projected benefit obligation of $ 210.6 million compared to plan assets of $ 203.0 million, resulting in an under-funded status of $ 7.6 million compared to an under-funded status of $ 28.8 million at December 31, 2023. The Company’s funded status improved during the year ended December 31, 2024 primarily due to the $ 20.0 million pension plan contribution. Any further changes in the assumptions underlying the Company’s pension values, including those that arise as a result of declines in equity markets and changes in interest rates, could result in increased pension obligation and pension cost which could negatively affect the Company’s consolidated financial position and results of operations in future periods. | text | 28.8 | monetaryItemType | text: <entity> 28.8 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had pension plans with a combined projected benefit obligation of $ 210.6 million compared to plan assets of $ 203.0 million, resulting in an under-funded status of $ 7.6 million compared to an under-funded status of $ 28.8 million at December 31, 2023. The Company’s funded status improved during the year ended December 31, 2024 primarily due to the $ 20.0 million pension plan contribution. Any further changes in the assumptions underlying the Company’s pension values, including those that arise as a result of declines in equity markets and changes in interest rates, could result in increased pension obligation and pension cost which could negatively affect the Company’s consolidated financial position and results of operations in future periods. </context> | us-gaap:DefinedBenefitPlanFundedStatusOfPlan |
As of December 31, 2024, the Company had pension plans with a combined projected benefit obligation of $ 210.6 million compared to plan assets of $ 203.0 million, resulting in an under-funded status of $ 7.6 million compared to an under-funded status of $ 28.8 million at December 31, 2023. The Company’s funded status improved during the year ended December 31, 2024 primarily due to the $ 20.0 million pension plan contribution. Any further changes in the assumptions underlying the Company’s pension values, including those that arise as a result of declines in equity markets and changes in interest rates, could result in increased pension obligation and pension cost which could negatively affect the Company’s consolidated financial position and results of operations in future periods. | text | 20.0 | monetaryItemType | text: <entity> 20.0 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had pension plans with a combined projected benefit obligation of $ 210.6 million compared to plan assets of $ 203.0 million, resulting in an under-funded status of $ 7.6 million compared to an under-funded status of $ 28.8 million at December 31, 2023. The Company’s funded status improved during the year ended December 31, 2024 primarily due to the $ 20.0 million pension plan contribution. Any further changes in the assumptions underlying the Company’s pension values, including those that arise as a result of declines in equity markets and changes in interest rates, could result in increased pension obligation and pension cost which could negatively affect the Company’s consolidated financial position and results of operations in future periods. </context> | us-gaap:DefinedBenefitPlanContributionsByEmployer |
At December 31, 2024, the projected benefit obligation, accumulated benefit obligation and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of the fair value of plan assets were $ 210.6 million, $ 209.2 million, and $ 203.0 million, respectively. | text | 210.6 | monetaryItemType | text: <entity> 210.6 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the projected benefit obligation, accumulated benefit obligation and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of the fair value of plan assets were $ 210.6 million, $ 209.2 million, and $ 203.0 million, respectively. </context> | us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation |
At December 31, 2024, the projected benefit obligation, accumulated benefit obligation and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of the fair value of plan assets were $ 210.6 million, $ 209.2 million, and $ 203.0 million, respectively. | text | 209.2 | monetaryItemType | text: <entity> 209.2 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the projected benefit obligation, accumulated benefit obligation and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of the fair value of plan assets were $ 210.6 million, $ 209.2 million, and $ 203.0 million, respectively. </context> | us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation |
At December 31, 2024, the projected benefit obligation, accumulated benefit obligation and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of the fair value of plan assets were $ 210.6 million, $ 209.2 million, and $ 203.0 million, respectively. | text | 203.0 | monetaryItemType | text: <entity> 203.0 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the projected benefit obligation, accumulated benefit obligation and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of the fair value of plan assets were $ 210.6 million, $ 209.2 million, and $ 203.0 million, respectively. </context> | us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets |
At December 31, 2023, the projected benefit obligation, accumulated benefit obligation and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of the fair value of plan assets were $ 224.0 million, $ 219.0 million and $ 195.2 million, respectively. | text | 224.0 | monetaryItemType | text: <entity> 224.0 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, the projected benefit obligation, accumulated benefit obligation and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of the fair value of plan assets were $ 224.0 million, $ 219.0 million and $ 195.2 million, respectively. </context> | us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation |
At December 31, 2023, the projected benefit obligation, accumulated benefit obligation and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of the fair value of plan assets were $ 224.0 million, $ 219.0 million and $ 195.2 million, respectively. | text | 219.0 | monetaryItemType | text: <entity> 219.0 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, the projected benefit obligation, accumulated benefit obligation and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of the fair value of plan assets were $ 224.0 million, $ 219.0 million and $ 195.2 million, respectively. </context> | us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation |
At December 31, 2023, the projected benefit obligation, accumulated benefit obligation and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of the fair value of plan assets were $ 224.0 million, $ 219.0 million and $ 195.2 million, respectively. | text | 195.2 | monetaryItemType | text: <entity> 195.2 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, the projected benefit obligation, accumulated benefit obligation and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of the fair value of plan assets were $ 224.0 million, $ 219.0 million and $ 195.2 million, respectively. </context> | us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets |
The other postretirement benefit obligation was determined using an assumed health care cost trend rate of 7.0 % in 2024 grading down to 5.0 % in 2033 and thereafter. The discount rate and health care cost trend rate assumptions are determined as of the measurement date. | text | 7.0 | percentItemType | text: <entity> 7.0 </entity> <entity type> percentItemType </entity type> <context> The other postretirement benefit obligation was determined using an assumed health care cost trend rate of 7.0 % in 2024 grading down to 5.0 % in 2033 and thereafter. The discount rate and health care cost trend rate assumptions are determined as of the measurement date. </context> | us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear |
The other postretirement benefit obligation was determined using an assumed health care cost trend rate of 7.0 % in 2024 grading down to 5.0 % in 2033 and thereafter. The discount rate and health care cost trend rate assumptions are determined as of the measurement date. | text | 5.0 | percentItemType | text: <entity> 5.0 </entity> <entity type> percentItemType </entity type> <context> The other postretirement benefit obligation was determined using an assumed health care cost trend rate of 7.0 % in 2024 grading down to 5.0 % in 2033 and thereafter. The discount rate and health care cost trend rate assumptions are determined as of the measurement date. </context> | us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1 |
The Company sponsors certain defined-contribution savings plans for eligible employees. Expense recognized related to these plans was $ 5.6 million, $ 4.5 million and $ 5.9 million during the years ended December 31, 2024, 2023, and 2022 | text | 5.6 | monetaryItemType | text: <entity> 5.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company sponsors certain defined-contribution savings plans for eligible employees. Expense recognized related to these plans was $ 5.6 million, $ 4.5 million and $ 5.9 million during the years ended December 31, 2024, 2023, and 2022 </context> | us-gaap:DefinedContributionPlanCostRecognized |
The Company sponsors certain defined-contribution savings plans for eligible employees. Expense recognized related to these plans was $ 5.6 million, $ 4.5 million and $ 5.9 million during the years ended December 31, 2024, 2023, and 2022 | text | 4.5 | monetaryItemType | text: <entity> 4.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company sponsors certain defined-contribution savings plans for eligible employees. Expense recognized related to these plans was $ 5.6 million, $ 4.5 million and $ 5.9 million during the years ended December 31, 2024, 2023, and 2022 </context> | us-gaap:DefinedContributionPlanCostRecognized |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.